Literature DB >> 9950175

Interactions between platelets and leukocytes during hemodialysis.

M Bonomini1, V Sirolli, S Stuard, N Settefrati.   

Abstract

The formation of platelet-leukocyte microaggregates has been observed in a variety of conditions. When platelets and leukocytes coaggregate, in general, a reciprocal activation occurs when both cells are activated, and the interactions between activated platelets and leukocytes may be relevant in both hemostasis and inflammatory processes. The study of platelet-leukocyte interactions in hemodialysis offers the novel aspect of cellular-cellular interaction as a new parameter for evaluating the biocompatibility of dialyzer membranes. This article reviews the investigations of the interactions between platelets and leukocytes during hemodialysis and the pathophysiologic implications which may stem from such interactions.

Mesh:

Substances:

Year:  1999        PMID: 9950175     DOI: 10.1046/j.1525-1594.1999.06271.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Role of antiplatelet therapy in the durability of hemodialysis access.

Authors:  Satinderjit Locham; Robert J Beaulieu; Hanaa Dakour-Aridi; Besma Nejim; Mahmoud B Malas
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

Review 2.  Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy.

Authors:  Mario Bonomini; Luca Piscitani; Lorenzo Di Liberato; Vittorio Sirolli
Journal:  Biomedicines       Date:  2022-04-03

3.  Hemoperfusion leads to impairment in hemostasis and coagulation process in patients with acute pesticide intoxication.

Authors:  Samel Park; Md-Imtiazul Islam; Ji-Hun Jeong; Nam-Jun Cho; Ho-Yeon Song; Eun-Young Lee; Hyo-Wook Gil
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.